- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06665009
How Nurses Use and Evaluate the Ampoule Peel Device: Comparing Manually Opened Vs. Device-Opened Ampoules
Utilization and Evaluation of Ampoule Peel Device
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to evaluate the ampoule peeling device in terms of safety, ease of use, time efficiency, difficulty of operation, and user satisfaction among nurses when opening ampoule bottles of different capacities. A key focus is to determine whether the device can reduce the risk of hand injuries and improve work efficiency.
Study Design and Procedures:
The study will be conducted in three phases:
Phase 1 (Experimental Study):
In a quiet and controlled environment, nurses will manually and using the ampoule peeling device, open different sizes of ampoule bottles (1ml, 2ml, 5ml, 10ml). Each participant will record the time required, safety, difficulty, success rate, and any incidents of hand injuries during the process. After completing both methods, participants will fill out subjective evaluation forms to assess their satisfaction with each method.
Phase 2 (Observational Study):
Nurses participating in Phase 1 will record the number of ampoule bottles they manually open over five consecutive days, noting the success rate and any hand injuries. Then, they will use the ampoule peeling device for the next five days and record similar data for comparison.
- Phase 3 (Observational Study):
After Phase 2, participants will have the freedom to choose between manual or device-assisted methods for a six-month period. At the end of this period, they will complete a survey summarizing their reasons for choosing a method, usage frequency, and overall safety and satisfaction levels.
Expected Outcomes:
It is anticipated that the ampoule peeling device will significantly improve safety, ease of use, and user satisfaction compared to manual methods. While there may not be a statistically significant difference in time efficiency, the overall success rate and safety should be enhanced.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chih-Cheng Wu, Master
- Phone Number: 4116 886-4-23592525
- Email: chihcheng.wu@gmail.com
Study Contact Backup
- Name: Ruei-Ling Chen
- Phone Number: 4135 886-4-23592525
- Email: gina811121@gmail.com
Study Locations
-
-
-
Taichung, Taiwan
- Recruiting
- Taichung Veterans General Hospital
-
Contact:
- Chih Cheng Wu, Master
- Phone Number: 4101 886-4-23592525
- Email: chihcheng.wu@gmail.com
-
Contact:
- Ruei-Ling Chen
- Phone Number: 4135 886-4-23592525
- Email: gina811121@gmail.com
-
Contact:
- Chih Cheng Wu, Master
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 16 nursing staff members from W72, W75, and the Department of Anesthesiology, who passed the preliminary tests and are willing to continue to the subsequent phases
Exclusion Criteria:
- Nursing staff unwilling to participate, unable to manually break ampoules, experiencing difficulty during the preparatory phase, or deciding to discontinue or withdraw during the process.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Manually Opened and Device-Opened
|
this study is to evaluate the ampoule peeling device in terms of safety, ease of use, time efficiency, difficulty of operation, and user satisfaction among nurses when opening ampoule bottles of different capacities
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
subjective estimation of safety
Time Frame: through study completion, an average of 1 year
|
subjective estimation of safety by a scale out of a maximum score of 5, with 1 stands for "strongly disagree" and 5 stands for "strongly agree".
|
through study completion, an average of 1 year
|
|
time efficiency
Time Frame: through study completion, an average of 1 year
|
time spent needed to open ampules manually or by ampoule openers by seconds
|
through study completion, an average of 1 year
|
|
events of injury
Time Frame: through study completion, an average of 1 year
|
events times and sites of injury from different volumes of ampoules
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ease of use
Time Frame: through study completion, an average of 1 year
|
subjective estimation of time-saving and difficulty by a scale out of a maximum score of 5, with 1 stands for "strongly disagree" and 5 stands for "strongly agree"
|
through study completion, an average of 1 year
|
|
difficulty of operation
Time Frame: through study completion, an average of 1 year
|
subjective estimation of time-saving and difficulty by a scale out of a maximum score of 5, with 1 stands for "strongly disagree" and 5 stands for "strongly agree"
|
through study completion, an average of 1 year
|
|
user satisfaction
Time Frame: through study completion, an average of 1 year
|
estimation of overall satisfaction rating (Out of a maximum score of 10, with 0 being very dissatisfied and 10 being very satisfied) for either open ampoules manually or by ampoule openers
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CG24481A
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.